Cargando…
Plasma tRNA-derived small RNAs signature as a predictive and prognostic biomarker in lung adenocarcinoma
BACKGROUND: The prevalence of lung adenocarcinoma (LUAD) has increased, thus novel biomarkers for its early diagnosis is becoming more important than ever. tRNA-derived small RNA (tsRNA) is a new class of non-coding RNA which has important regulatory roles in cancer biology. This study was designed...
Autores principales: | Wang, Jun, Liu, Xianyu, Cui, Weifang, Xie, Qun, Peng, Wei, Zhang, Heng, Gao, Yang, Zhang, Chunfang, Duan, Chaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812260/ https://www.ncbi.nlm.nih.gov/pubmed/35115004 http://dx.doi.org/10.1186/s12935-022-02481-6 |
Ejemplares similares
-
tRNA-derived small RNAs: novel regulators of cancer hallmarks and targets of clinical application
por: Li, Xizhe, et al.
Publicado: (2021) -
Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patients
por: Liu, Xianyu, et al.
Publicado: (2022) -
tRNA Modifications and Modifying Enzymes in Disease, the Potential Therapeutic Targets
por: Cui, Weifang, et al.
Publicado: (2023) -
An individualized immune prognostic signature in lung adenocarcinoma
por: Sun, Liangdong, et al.
Publicado: (2020) -
Recognition of immune-related tumor antigens and immune subtypes for mRNA vaccine development in lung adenocarcinoma
por: Zhao, Deze, et al.
Publicado: (2022)